Insights On Downstream Manufacturing

  1. Cartridge Filling: Where Precision, Process Control, And Experience Matter 9/1/2026

    Cartridge drug delivery demands strict controls to guarantee dose accuracy. Early development and testing eliminate variability, prevent defects, and protect patient safety.

  2. Beyond Protein A: Efficient Purification Strategies For Misbehaving mAbs 9/1/2026

    Next-generation antibody formats require more precise purification strategies. Explore how subdomain-specific VHH ligands can address structural heterogeneity, improve purity, and preserve stability.

  3. Single-Use Clarification Across Process Scales 9/1/2026

    Gain insight into how combining centrifugation with targeted depth and chromatographic clarification can reduce filter demand, ease facility constraints, and support efficient mAb harvest.

  4. Enhancing mAb Production: Advanced Downstream Purification Strategies 9/1/2026

    Explore how process optimization can address downstream mAb manufacturing bottlenecks, reduce labor and consumable costs, and support more efficient production without compromising performance.

  5. A Practical Roadmap For Column Sizing, System Selection, And GxP Readiness 9/1/2026

    Chromatography scale-up depends on aligning different factors. Learn which factors can help maintain process consistency, manage risk, and support the transition from development to manufacturing.

  6. Chromatography Polishing In The Age Of Intensification 9/1/2026

    As upstream processes intensify, chromatography polishing must handle higher loads and evolving impurity profiles. Modern strategies can improve clearance, extend resin life, and maintain throughput.

  7. Improved Clearance Of Host Cell Proteins After Virus Inactivation 9/1/2026

    Learn how post-viral inactivation filtration can support precipitate and host cell protein removal while balancing throughput, purity and cost across different feeds and process development conditions.

  8. Planning For Scale Up: Building For Long Term Flexibility 8/31/2026

    Decisions made during clinical manufacturing have lasting consequences at commercial scale. This article examines how fill/finish equipment choices shape long-term flexibility, throughput, and operational continuity.

  9. Minimizing Particulate Risk: Designing For Control 8/31/2026

    Effective particulate control in aseptic fill/finish operations requires coordinated design decisions spanning airflow configuration, static mitigation, transport mechanisms, and closure handling.

  10. Protecting Your Drug Product: Integrating Engineering And Quality 8/31/2026

    Engineering decisions in fill/finish directly shape product quality and sterility assurance. This article examines how inert gas purging, plunger placement, dosing verification, and barrier systems interact across line design.